Home
Home

Verastem

Verastem Reports Year-End 2012 Financial Results

Verastem Reports Year-End 2012 Financial Results
Yahoo

ImmunoCellular CEO Steps Down But Leaves Company Well Positioned

ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Seeking Alpha

AstraZeneca Wins This Summer's Pharma Acquisition Spree

AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha

Eli Lilly, Verastem and the Defenders of Shareholder Value

Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com

Verastem's Chances Are Slimmer Than Investment Banks Would Have You Think

Verastem's Chances Are Slimmer Than Investment Banks Would Have You Think
Seeking Alpha

10 Biotechs Targeting Cancer Stem Cell Destruction

10 Biotechs Targeting Cancer Stem Cell Destruction
Minyanville

Verastem IPO Looks Like Risky Bet

Verastem IPO Looks Like Risky Bet
TheStreet.com

IPO Preview: Verastem

IPO Preview: Verastem
Seeking Alpha

With IPO pending, Verastem raises $20M

With IPO pending, Verastem raises $20M
Bizjournals.com